Browsing by Author Chan, M.Y.

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 1 to 20 of 41  next >
Issue DateTitleAuthor(s)
Jul-2013A single-center experience of transitioning from a routine transfemoral to a transradial intervention approach in ST-elevation myocardial infarction: Impact on door-to-balloon time and clinical outcomesKajiya, T.; Agahari, F.; Wai, K.L.; Tai, B.-C. ; Lee, C.-H.; Chan, K.-H.; Teo, S.G.; Richards, A.M.; Tan, H.-C.; Low, A.F.; Chan, M.Y.
Nov-2011Acute myocardial infarction in young Asian women: A comparative study on Chinese, Malay and Indian ethnic groupsXie, C.B.; Chan, M.Y.; Teo, S.G. ; Low, A.F.; Tan, H.C.; Lee, C.H.
2012Adiponectin Profile and Coronary Plaque Vulnerability: A Virtual Histology Intravascular Ultrasound StudyLee, C.-H. ; Hau, W.K.; Tai, B.C. ; Chan, M.Y.; Saw, B; Phua, Q.H. ; Low, A.F.; Yeo, T.C. ; Richards, A.M. ; Tan, H.C. 
Dec-2012Adiponectin profile in asian patients undergoing coronary revascularization and its association with plaque vulnerability: IDEAS-ADIPO studyLee, C.-H.; Hau, W.K.T.; Tai, B.-C. ; Chan, M.Y.; Saw, B.; Phua, Q.-H.; Low, A.F.; Yeo, T.-C.; Richards, A.M.; Tan, H.-C.
Nov-2012Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary interventionLi, Y.; Tai, B.-C. ; Sia, W.; Phua, Q.-H.; Richards, M.A.; Low, A.; Chan, K.-H.; Teo, S.-G. ; Sim, T.-B.; Lee, C.-H.; Roe, M.T.; Yeo, T.-C.; Tan, H.-C.; Chan, M.Y.
2006Antecedent risk factors and their control in young patients with a first myocardial infarctionChan, M.Y.; Sutandar, A.; Tan, H.C. ; Chia, B.L. ; Wong, H.B.; Woo, K.S.
Jun-2006Authors' reply [5]Chan, M.Y.; Sang, W.K.; Bee, W.H.; Cheem, T.H. 
Feb-2004Bis(N,N-dibenzyldithiocarbamato)zinc(II)Decken, A.; Gossage, R.A.; Chan, M.Y.; Lai, C.S. ; Tiekink, E.R.T. 
Jun-2004Bis(N-cyclohexyl,N-methyldithiocarbamato)zinc(II)Chan, M.Y.; Lai, C.S. ; Tiekink, E.R.T. 
2009Characteristics, and disease control and complications of hypertensive patients in primary-care - A community-based study in SingaporeTan, E.K.; Chung, W.L.; Koh, W.-P. ; Lew, Y.J.; Chan, M.Y.; Wong, T.Y. 
2011Clinical characteristics and prognostic importance of mild-to-moderate noninfarct-related coronary artery disease in patients with first ST-elevation myocardial infarctionSoo, W.M. ; Chan, M.Y.; Beck, L.; Lim, S.L.; Lee, C.-H. ; Poh, K.K. 
Jan-2012Correlation between high density lipoprotein-cholesterol and remodeling index in patients with coronary artery disease: IDEAS (IVUS diagnostic evaluation of atherosclerosis in Singapore)-HDL studyLee, C.-H.; Tai, B.-C. ; Lim, G.-H.; Chan, M.Y.; Low, A.F.; Tan, K.C.; Chia, B.-L.; Tan, H.-C.
Apr-2012CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjectsChan, M.Y.; Tan, K.; Tan, H.-C.; Huan, P.-T.; Li, B.; Phua, Q.-H.; Lee, H.-K.; Lee, C.-H.; Low, A.; Becker, R.C.; Ong, W.-C.; Richards, M.A.; Salim, A. ; Tai, E.-S.; Koay, E.
15-Jul-2011Effectiveness and safety of the genous endothelial progenitor cell-capture stent in acute ST-elevation myocardial infarctionLow, A.F.; Lee, C.-H.; Teo, S.-G. ; Chan, M.Y.; Tay, E.; Lee, Y.-P.; Chong, E.; Co, M.; Tin Hay, E.; Lim, Y.-T.; Tan, H.-C.
2015Erratum : Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in st-segment elevation myocardial infarction (JACC: Cardiovascular Interventions (2015) 8 (18997))Brugaletta, S.; Gori, T.; Low, A.F. ; Tousek, P.; Pinar, E.; Gomez-Lara, J.; Scalone, G.; Schulz, E.; Chan, M.Y.; Kocka, V.; Hurtado, J.; Gomez-Hospital, J.A.; M?nzel, T.; Lee, C.-H. ; Cequier, A.; Vald?s, M.; Widimsky, P.; Serruys, P.W.; Sabat?, M.
2013Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)Kajiya, T.; Liang, M.; Sharma, R.K.; Lee, C.-H. ; Chan, M.Y.; Tay, E. ; Chan, K.-H. ; Tan, H.-C. ; Low, A.F. 
2013Excessive daytime sleepiness is associated with longer culprit lesion and adverse outcomes in patients with coronary artery diseaseLee, C.-H.; Ng, W.-Y. ; Hau, W.; Ho, H.-H.; Tai, B.-C. ; Chan, M.Y.; Richards, A.M.; Tan, H.-C.
Sep-2005Fluvastatin: Efficacy and safety in reducing cardiac eventsChan, M.Y.; Lee, C.H. 
Oct-2012Hemophagocytic lymphohistiocytosis with isolated central nervous system reactivation and optic nerve involvementChong, K.W.; Lee, J.H. ; Choong, C.T.; Med, M.; Chan, D.W.S.; Fortier, M.V.; Chan, M.Y.
2015High-grade culprit lesions are a common cause of ST?segment elevation myocardial infarctionLiang, M.; Kajiya, T.; Chan, M.Y.; Tay, E. ; Lee, C.-H. ; Richards, A.M. ; Low, A.F. ; Tan, H.C.